Determination of ED50 values for praziquantel in praziquantel-resistant and -susceptible Schistosoma mansoni isolates

被引:107
作者
Cioli, D
Botros, SS
Wheatcroft-Francklow, K
Mbaye, A
Southgate, V
Tchuenté, LAT
Pica-Mattoccia, L
Troiani, AR
El-Din, SHS
Sabra, ANA
Albin, J
Engels, D
Doenhoff, MJ
机构
[1] Univ Coll N Wales, Sch Biol Sci, Bangor LL57 2UW, Gwynedd, Wales
[2] Inst Cell Biol, I-00016 Monterotondo, Rome, Italy
[3] Theodor Bilharz Res Inst, Dept Pharmacol, Giza 12411, Egypt
[4] Reg Med St Louis, Programme Lutte Contre Bilharzioses, St Louis, Senegal
[5] Nat Hist Museum, Dept Zool, London SW7 5BD, England
[6] Ctr Schistosomiasis & Parasitol, Yaounde, Cameroon
[7] WHO, Communicalbe Dis Control Prevent & Eradicat, Parasit Dis & Vector Control, CH-1211 Geneva 27, Switzerland
基金
英国惠康基金;
关键词
Schistosoma mansoni; praziquantel; ED50; drug-resistance;
D O I
10.1016/j.ijpara.2004.05.001
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
The dose of praziquantel required to kill 50% of adult worms in vivo (i.e. the ED50) was estimated for nine different isolates of Schistosoma mansoni in infected mice. Four of the isolates were selected because they had not knowingly been in contact with the drug (i.e. they were putatively praziquantel-susceptible). Five putatively praziquantel-resistant isolates were chosen because they had been selectively bred for drug-resistance in the laboratory and/or had previously been shown to be relatively resistant to praziquantel in the field. The work was performed in three laboratories in different countries using pre-agreed and comparable experimental protocols. All four praziquantel-susceptible isolates had ED(50)s estimated to be < 100 mg/kg (mean = 70 +/- 7 SD; median = 68), while all five putatively praziquantel-resistant isolates had estimated ED(50)s > 100 mg/kg (mean = 209 +/- 48 SD; median = 192). Thus, the five praziquantel-resistant isolates, including two that had been subjected to drug pressure during more than 20 passages in mice, had drug ED(50)s that were approximately three times as great as those of the praziquantel-susceptible isolates. Two of the five isolates in the putatively resistant group had previously been passaged 15 or more times in mice without administration of drug-pressure, but had ED(50)s consistent with the other three isolates in the group, indicating that the trait of praziquantel-resistance did not necessarily impair biological fitness during laboratory passage. The protocols used here to estimate the praziquantel ED(50)s Of S. mansoni isolates should be useful for establishing and monitoring the drug susceptibility/resistance profiles of parasite isolates freshly obtained from endemic areas, particularly those in which increased usage of the drug is likely to occur. (C) 2004 Australian Society for Parasitology Inc. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:979 / 987
页数:9
相关论文
共 35 条
[1]   The development of resistance to anthelmintics: A perspective with an emphasis on the antischistosomal drug praziquantel [J].
Bennett, JL ;
Day, T ;
Liang, FT ;
Ismail, M ;
Farghaly, A .
EXPERIMENTAL PARASITOLOGY, 1997, 87 (03) :260-267
[2]   Praziquantel: is there real resistance and are there alternatives? [J].
Cioli, D .
CURRENT OPINION IN INFECTIOUS DISEASES, 2000, 13 (06) :659-663
[3]   Chemotherapy of schistosomiasis: An update [J].
Cioli, D .
PARASITOLOGY TODAY, 1998, 14 (10) :418-422
[4]   Action starts now to control disease due to schistosomiasis and soil-transmitted helminthiasis [J].
Crompton, DWT ;
Engels, D ;
Montresor, A ;
Neira, MP ;
Savioli, L .
ACTA TROPICA, 2003, 86 (2-3) :121-124
[5]   Praziquantel and the control of schistosomiasis [J].
Doenhoff, MJ ;
Kimani, G ;
Cioli, D .
PARASITOLOGY TODAY, 2000, 16 (09) :364-366
[6]   Resistance of Schistosoma mansoni to praziquantel:: is there a problem? [J].
Doenhoff, MJ ;
Kusel, JR ;
Coles, GC ;
Cioli, D .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2002, 96 (05) :465-469
[7]   Is schistosomicidal chemotherapy sub-curative? Implications for drug resistance [J].
Doenhoff, MJ .
PARASITOLOGY TODAY, 1998, 14 (10) :434-435
[8]   Schistosoma mansoni: Maturation rate and drug susceptibility of different geographic isolates [J].
Fallon, PG ;
Mubarak, JS ;
Fookes, RE ;
Niang, M ;
Butterworth, AE ;
Sturrock, RF ;
Doenhoff, MJ .
EXPERIMENTAL PARASITOLOGY, 1997, 86 (01) :29-36
[9]   SHORT REPORT - DIMINISHED SUSCEPTIBILITY TO PRAZIQUANTEL IN A SENEGAL ISOLATE OF SCHISTOSOMA-MANSONI [J].
FALLON, PG ;
STURROCK, RF ;
NIANG, CM ;
DOENHOFF, MJ .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1995, 53 (01) :61-62
[10]   DRUG-RESISTANT SCHISTOSOMIASIS - RESISTANCE TO PRAZIQUANTEL AND OXAMNIQUINE INDUCED IN SCHISTOSOMA-MANSONI IN MICE IS DRUG-SPECIFIC [J].
FALLON, PG ;
DOENHOFF, MJ .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1994, 51 (01) :83-88